Novo Nordisk Investigational Site

Burlington, Vermont 05401

0 studies enrolling now · 3 studies all time

What they study most

Acquired Bleeding Disorder, Chronic Kidney Disease, End-Stage Renal Disease, Hepatobiliary Disorders, Intracerebral Haemorrhage, Non-alcoholic Steatohepatitis

Studies at this site

• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early
• Recombinant Factor VIIa in Acute Intracerebral Haemorrhage — Completed